Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Reipert · SciRah

Researcher profile · Semantic Scholar

B. Reipert

Share profile

B. Reipert — researcher profile on SciRah

h-index: 29
Works: 131
Citations: 3,721

Most-cited papers

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Shawn Whelan, C. Hofbauer, F. Horling, P. Allacher +8 more
2013Blood186 citations
Semantic Scholar
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development
K. Kurnik, C. Bidlingmaier, Werner Engl, H. Chehadeh +2 more
2010Haemophilia186 citations
Semantic Scholar
BAX 335 hemophilia B gene therapy clinical trial results - potential impact of CpG sequences on gene expression.
Barbara A. Konkle, C. Walsh, Miguel A. Escobar, N. Josephson +12 more
2020Blood168 citations Open access
Semantic Scholar
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
Anita Kruzik, D. Fetahagic, B. Hartlieb, Sebastian Dorn +5 more
2019Molecular Therapy: Methods & Clinical Development165 citations Open access
Semantic Scholar
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
C. Lubich, P. Allacher, M. De La Rosa, A. Bauer +6 more
2016Pharmaceutical Research151 citations
Semantic Scholar
Taking immunogenicity assessment of therapeutic proteins to the next level.
I. C. Büttel, P. Chamberlain, Y. Chowers, F. Ehmann +20 more
2011Biologicals (Print)145 citations
Semantic Scholar
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
J. Astermark, C. Altisent, A. Bátorová, M. Diniz +10 more
2010Haemophilia143 citations Open access
Semantic Scholar
PEGylated Biopharmaceuticals
Inge A. Ivens, William E. Achanzar, A. Baumann, Annamaria Brändli-Baiocco +12 more
2015Toxicologic pathology (Print)124 citations Open access
Semantic Scholar
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans.
C. Hofbauer, Shawn Whelan, Maria Hirschler, P. Allacher +12 more
2015Blood119 citations Open access
Semantic Scholar
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
B. Reipert, Pauline M. W. Van Den Helden, H. Schwarz, C. Hausl
2007British Journal of Haematology113 citations Open access
Semantic Scholar
The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells
J. Kober, J. Leitner, Christoph Klauser, Ramona Woitek +8 more
2008European Journal of Immunology95 citations Open access
Semantic Scholar
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
K. Steinitz, P. V. van Helden, B. Binder, D. Wraith +9 more
2012Blood73 citations Open access
Semantic Scholar
Anti-factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study.
A. Tiede, C. Hofbauer, S. Werwitzke, P. Knöbl +9 more
2016Blood57 citations Open access
Semantic Scholar
Dangerous liaisons: how the immune system deals with factor VIII
A. Wróblewska, B. Reipert, K. P. Pratt, J. Voorberg
2013Journal of Thrombosis and Haemostasis48 citations Open access
Semantic Scholar
In‐depth comparison of N‐glycosylation of human plasma‐derived factor VIII and different recombinant products: from structure to clinical implications
K. Canis, J. Anzengruber, E. Garenaux, M. Feichtinger +5 more
2018Journal of Thrombosis and Haemostasis38 citations Open access
Semantic Scholar
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.
C. Hofbauer, Sylvia Kepa, M. Schemper, P. Quehenberger +4 more
2016Blood34 citations Open access
Semantic Scholar
Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model.
P. V. van Helden, Sabine Unterthurner, C. Hermann, M. Schuster +8 more
2011Blood32 citations Open access
Semantic Scholar
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.
B. Reipert, B. Gangadharan, C. Hofbauer, V. Berg +17 more
2020Blood Advances31 citations Open access
Semantic Scholar
Variation of anti‐Fas antibodies in different lots of intravenous immunoglobulin
B. Reipert, M. Stellamor, M. Poell, J. Ilas +5 more
2008Vox Sanguinis31 citations
Semantic Scholar
Intravenous Immunoglobulins Are a Therapeutic Option in the Treatment of Multiple Sclerosis Relapse
I. Elovaara, H. Kuusisto, Xing-Chen Wu, S. Rinta +2 more
2011Clinical neuropharmacology29 citations
Semantic Scholar
Opportunities and limitations of mouse models humanized for HLA class II antigens
B. Reipert, K. Steinitz, P. V. van Helden, Sabine Unterthurner +4 more
2009Journal of Thrombosis and Haemostasis29 citations Open access
Semantic Scholar
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays
Anita Kruzik, H. Koppensteiner, D. Fetahagic, B. Hartlieb +9 more
2019Human Gene Therapy Methods28 citations Open access
Semantic Scholar
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.
Jesse D. Lai, P. Moorehead, Kate Sponagle, K. Steinitz +3 more
2016Blood28 citations Open access
Semantic Scholar
Modulation of factor VIII‐specific memory B cells
B. Reipert, P. Allacher, C. Hausl, A. G. Pordes +7 more
2010Haemophilia28 citations Open access
Semantic Scholar
Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.
N. Pigard, I. Elovaara, H. Kuusisto, Raija Paalavuo +4 more
2009Journal of Neuroimmunology27 citations
Semantic Scholar
Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9.
P. Allacher, C. Baumgartner, A. G. Pordes, R. Ahmad +2 more
2011Blood26 citations Open access
Semantic Scholar
Requirements for Co-Stimulation in T-Cell Dependent and T-Cell Independent Re-Stimulation of FVIII-Specific Memory B Cells
A. G. Pordes, C. Hausl, P. Allacher, R. Ahmad +4 more
200820 citations
Semantic Scholar
Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs
Janine Becker-Gotot, Mirjam Meissner, V. Kotov, B. Jurado-Mestre +9 more
2022Journal of Clinical Investigation18 citations Open access
Semantic Scholar
Immunoglobulins stimulate cultured Schwann cell maturation and promote their potential to induce axonal outgrowth
Nevena Tzekova, A. Heinen, S. Bunk, C. Hermann +3 more
2015Journal of Neuroinflammation18 citations Open access
Semantic Scholar
Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responses.
B. Reipert
2014Hematology. American Society of Hematology. Education Program18 citations Open access
Semantic Scholar
T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist.
A. G. Pordes, C. Baumgartner, P. Allacher, R. Ahmad +4 more
2011Blood18 citations Open access
Semantic Scholar
Animal models of inhibitors
B. Reipert, V. Arruda, D. Lillicrap
2010Haemophilia17 citations Open access
Semantic Scholar
B-cell memory against factor VIII.
B. Reipert
2016Cellular Immunology14 citations
Semantic Scholar
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency
Wen-Jing Cao, Biao Dong, Franziska Horling, Jenni Firrman +17 more
2020Molecular Therapy: Methods & Clinical Development13 citations Open access
Semantic Scholar
Blockade of the costimulatory CD28‐B7 family signal axis enables repeated application of AAV8 gene vectors
M. Frentsch, A. Japp, M. Dingeldey, Nadine Matzmohr +4 more
2020Journal of Thrombosis and Haemostasis12 citations Open access
Semantic Scholar
IVIG induces apoptotic cell death in CD56dim NK cells resulting in inhibition of ADCC effector activity of human PBMC.
S. Bunk, P. Ponnuswamy, A. Trbic, M. Mališauskas +9 more
2019Clinical Immunology12 citations Open access
Semantic Scholar
A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions
C. Lubich, M. Mališauskas, T. Prenninger, T. Würz +4 more
2015Pharmaceutical Research12 citations
Semantic Scholar
Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors
Helmut Schweiger, J. Rejtő, C. Hofbauer, V. Berg +7 more
2021Blood Advances10 citations Open access
Semantic Scholar
Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophilia
J. Saint-Remy, B. Reipert, D. Monroe
2012Haemophilia9 citations Open access
Semantic Scholar
Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms
Maria T. Georgescu, P. Moorehead, A. van Velzen, Kate Nesbitt +5 more
2018Haematologica8 citations Open access
Semantic Scholar
Comparative analysis of marketed factor VIII products: recombinant products are not alike vis‐a‐vis soluble protein aggregates and subvisible particles
J. Anzengruber, C. Lubich, T. Prenninger, Alessandro Gringeri +3 more
2018Journal of Thrombosis and Haemostasis8 citations Open access
Semantic Scholar
Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes
P. Turecek, B. Abbühl, S. Tangada, M. Chapman +12 more
2015Expert Review of Clinical Pharmacology8 citations
Semantic Scholar
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
Einas Elsheikh, M. Lavin, L. A. Heck, Niamh Larkin +25 more
2023Journal of Thrombosis and Haemostasis7 citations Open access
Semantic Scholar
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study
O. Oleshko, S. Werwitzke, Annika Klingberg, T. Witte +10 more
2022Blood Advances7 citations Open access
Semantic Scholar
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A
F. Horling, B. Reipert, P. Allacher, Werner Engl +2 more
2024Blood Advances6 citations Open access
Semantic Scholar
How Full-Length FVIII Benefits from Its Heterogeneity – Insights into the Role of the B-Domain
J. Anzengruber, M. Feichtinger, Philipp Michael Bärnthaler, N. Haider +6 more
2019Pharmaceutical Research6 citations Open access
Semantic Scholar
Surgical Injury Alone Does Not Provoke the Development of Factor VIII Inhibitors in Mouse Models of Hemophilia A
P. Moorehead, Braden Waters, Kate Sponagle, K. Steinitz +2 more
20126 citations
Semantic Scholar
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys
H. Glantschnig, A. Bauer, K. Benamara, M. Dockal +16 more
2019Journal of Pharmacology and Experimental Therapeutics4 citations Open access
Semantic Scholar
Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures
B. Gangadharan, B. Reipert, V. Berg, F. Scheiflinger +16 more
2018Blood4 citations
Semantic Scholar
Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)
B. Reipert, B. Gangadharan, C. Hofbauer, F. Scheiflinger +13 more
20164 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Scheiflinger×18
Invite
F. Scheiflinger — researcher profile on SciRah
P. Allacher×9
Invite
P. Allacher — researcher profile on SciRah
F. Horling×8
Invite
F. Horling — researcher profile on SciRah
H. Schwarz×8
Invite
H. Schwarz — researcher profile on SciRah

×7

Invite

C. Hofbauer — researcher profile on SciRah

M. De La Rosa×7

Invite

M. De La Rosa — researcher profile on SciRah

Invite

C. Male — researcher profile on SciRah

Invite

K. Steinitz — researcher profile on SciRah

Invite

M. Schuster — researcher profile on SciRah

Invite

R. Ahmad — researcher profile on SciRah

M. Mališauskas×5

Invite

M. Mališauskas — researcher profile on SciRah

Invite

J. Ilas — researcher profile on SciRah